W A Breeman

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

E. P. Krenning, WH Bakker, P P Kooij et al. · PubMed · 1992 · 422 citations

Engineering, Pathology, Positron Emission Tomography +18

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

M. de Jong, W A Breeman, WH Bakker et al. · PubMed · 1998 · 210 citations

Engineering, Chemoprevention Strategy, In-labeled Somatostatin +21

Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate.

Willem H. Bakker, W A Breeman, D. J. Kwekkeboom et al. · PubMed · 2006 · 45 citations

Engineering, Radiation Exposure, Practical Aspects +21

Improving radiopeptide pharmacokinetics by adjusting experimental conditions for bombesin receptor-targeted imaging of prostate cancer.

Corrina M. de Ridder, W M Van Weerden, W A Breeman et al. · PubMed · 2012 · 13 citations